Astria Therapeutics Inc (NAS:ATXS)
$ 9.17 -0.11 (-1.19%) Market Cap: 503.55 Mil Enterprise Value: 235.18 Mil PE Ratio: 0 PB Ratio: 1.85 GF Score: 36/100

Q3 2023 Astria Therapeutics Inc Earnings Call Transcript

Nov 13, 2023 / 01:30PM GMT
Release Date Price: $4.49 (-2.39%)
Operator

Good morning. And welcome to the Astria Therapeutics quarter three 2023 corporate update. (Operator Instructions) As a reminder, this call is being recorded. And a replay will be made available on the Astria website following the conclusion of the event. I'd now like to turn the call over to Liz Higgins, Director of Communications and Investor Relations at Astria Therapeutics. Please go ahead, Liz.

Liz Higgins
Astria Therapeutics, Inc. - Director of Communications and Investor Relations

Thank you, Tara. Welcome to today's Astria Therapeutics Q3 2023 conference call. With me today are Jill Milne, Chief Executive Officer; Christopher Morabito, Chief Medical Officer; Andrew Komjathy, Chief Commercial Officer; Andrea Matthews, Chief Business Officer; and Noah Clauser, Chief Financial Officer.

We issued a press release this morning summarizing our corporate update and third quarter financial results, which we will reference on today's call and is available on our website. We are also using slides during today's call that are available within the Events and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot